FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Temasek Holdings (Private) Ltd		 2. Date of Event Requiring Statement (MM/DD/YYYY)
8/19/2022 

 3. Issuer Name and Ticker or Trading Symbol

Akili, Inc. [AKLI]
(Last)        (First)        (Middle)

60B ORCHARD ROAD, #06-18 TOWER, 2, THE ATRIUM@ORCHARD		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

SINGAPORE, U0 238891      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 10336425 I (1)See Footnote (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Earnout Shares  (2)(3)8/19/2027 Common Stock 1172697  (2)(3)I (1)See Footnote (1)
Explanation of Responses:
(1) The securities reported herein are directly owned by TLS Beta Pte. Ltd. ("TLS Beta"), which is a direct wholly-owned subsidiary of Temasek Life Sciences Private Limited ("Temasek Life Sciences"). Temsaek Life Sciences is a direct wholly-owned subsidiary of Fullerton Management Pte Ltd ("FMPL"), which in turn is a direct wholly-owned subsidiary of Temasek Holdings (Private) Limited ("Temasek Holdings"). Temasek Life Sciences, FMPL and Temasek Holdings may therefore be deemed to have or share beneficial ownership of the securities directly owned by TLS Beta.
(2) Represents shares of the Issuer's common stock deposited into an escrow account for the benefit of TLS Beta (the "Earnout Shares") pursuant to the Agreement and Plan of Merger, dated as of January 26, 2022 (the "Merger Agreement"), by and among Social Capital Suvretta Holdings Corp. I, a Cayman Islands exempted company with limited liability ("SCS"), Karibu Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of SCS, and Akili Interactive Labs, Inc., a Delaware corporation. The Earnout Shares are subject to release from escrow to TLS Beta in three equal tranches upon the daily volume weighted average price of a share of the Issuer's common stock reaching $15.00/share, $20.00/share and $30.00/share, respectively, over any 20 trading days within any 30 consecutive trading day period following August 19, 2022 and prior to August 19, 2027, in each case, on the terms set forth in the Merger Agreement.
(3) (Continued from footnote 2) Before the Earnout Shares are released, such shares: (i) entitle TLS Beta to the rights of the holders of shares of the Issuer's common stock, including the right to vote or to receive dividends, distributions or other payment of any kind in respect of such Earnout Shares; (ii) will not bear interest; and (iii) are not assignable or transferable, except by operation of law, will or intestacy.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Temasek Holdings (Private) Ltd
60B ORCHARD ROAD, #06-18 TOWER
2, THE ATRIUM@ORCHARD
SINGAPORE, U0 238891
X

TLS Beta Pte. Ltd.
60B ORCHARD ROAD, #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE, U0 238891
X

Temasek Life Sciences Private Ltd
60B ORCHARD ROAD, #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE, U0 238891
X

Fullerton Management Pte Ltd
60B ORCHARD ROAD, #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE, U0 238891
X
Signatures
TLS Beta Pte. Ltd., By: /s/ Zahedah Abdul Rashid, Director8/26/2022
**Signature of Reporting PersonDate

Temasek Life Sciences Private Limited, By: /s/ Lim Siew Lee Sherlyn, Director8/26/2022
**Signature of Reporting PersonDate

Fullerton Management Pte Ltd, By: /s/ Gregory Tan, Director8/26/2022
**Signature of Reporting PersonDate

Temasek Holdings (Private) Limited, By: /s/ Jason Norman Lee, Authorized Signatory8/26/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Social Capital Suvretta ... (NASDAQ:DNAA)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Social Capital Suvretta ... Charts.
Social Capital Suvretta ... (NASDAQ:DNAA)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Social Capital Suvretta ... Charts.